Skip to main content
SpringerLink
Log in

Adrenal Gland

  • Chapter
The Pathophysiologic Basis of Nuclear Medicine

  • 1580 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 279.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 359.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aron DC, Tyrrell JB (1997) Glucocorticoids and adrenal androgens. In: Greenspan FS, Strewler GJ (eds) Basic and clinical endocrinology, 5th edn. Appleton and Lange, Norwalk, Conn, p 318

    Google Scholar 

  2. Goldfien A (1997) Adrenal medulla. In: Greenspan FS, Strewler GJ (eds) Basic and clinical endocrinology, 5th edn. Appleton and Lange, Norwalk, Conn, p 382

    Google Scholar 

  3. Ryan JJ, Rezkalla MA, Rizk SN, Peterson KG, Wiebe RH (1995) Testosterone-secreting adrenal adenoma that contained crystalloids of Reinke in an adult female patient. Mayo Clin Proc 70:380–383

    Article  PubMed  CAS  Google Scholar 

  4. Lynn MD, Gross MD, Shapiro B, Bassett D (1986) The influence of hypercholesterolemia on the adrenal uptake and metabolic handling of I-131 6-beta-iodomethyl-19-norcholesterol (NP-59). Nucl Med Comm 1:631–635

    Article  Google Scholar 

  5. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193–202

    Article  PubMed  Google Scholar 

  6. Huether SE, Tomky D (1998) Alterations of hormonal regulation. In: McCance KL, Huether SE (eds) Pathophysiology, the biologic basis for disease in adults and children, 3rd edn. Mosby, St Louis, p 700

    Google Scholar 

  7. Spencer RP (1998) Tumor-seeking radiopharmaceuticals: nature and mechanisms. In: Murray IP, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, HongKong, p 764

    Google Scholar 

  8. Hoefnagel CA, de Kraker J (1998) Childhood neoplasia. In: Murray IP, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Hong Kong, p 1002

    Google Scholar 

  9. Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cummings D, Hughes J, et al (1995) I-123 MIBG scintigraphy in adults, a report of clinical experience. Clin Nucl Med 20:147

    Article  PubMed  CAS  Google Scholar 

  10. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ (1994) Iodine-123 MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 35:1753–1756

    PubMed  CAS  Google Scholar 

  11. Parisi MT, Sandler ED, Hattner RS (1992) The biodistribution of metaiodobenzylguanidine. Semin Nucl Med 22:46–48

    Article  PubMed  CAS  Google Scholar 

  12. Okuyama C, Ushijima Y, Kubota T, Yoshida T, Nakai T, Kobayashi K, Nishimura T (2003) 123I-Metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue. J Nucl Med 44:1421–1425

    PubMed  CAS  Google Scholar 

  13. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH (1985) Iodine-131 metaiodobenzyl-guanidine in the locating of suspected pheochromocytoma: experience in 400 cases. J Ncl Med 26:576

    CAS  Google Scholar 

  14. Paltiel HJ, Gelfand MJ, Elgazzar AH, Washburn LC, Harris RE, Masters PR, Golsch GJ (1994) Neural crest tumors: I-123 MIBG imaging in children. Radiology 190:118

    Google Scholar 

  15. Limouris GS, Giannakopoulos V, Stavraka A, Toubanakis N, Vlahos L (1997) Comparison of In-111 pentetreotide, Tc-99m (V) DMSA and I-123 mIBG scintimaging in neural crest tumors. Anticancer Res 17:1589–1592

    PubMed  CAS  Google Scholar 

  16. Shalaby-Rana E, Majd M, Andrich MP, Movassaghi N (1997) In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome. Clin Nucl Med 22:315–319

    Article  PubMed  CAS  Google Scholar 

  17. Schilling FH, Bihl H, Jacobsson H, Ambros PF, Martinsson T, Borgstrom P, Schwarz K, et al (2000) Combined (111)Inpentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information. Med Pediatr Oncol 35:688–691

    Article  PubMed  CAS  Google Scholar 

  18. Kropp J, Hofmann M, Bihl H (1997) Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor? Anticancer Res 17:1583–1588

    PubMed  CAS  Google Scholar 

  19. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1–6

    PubMed  CAS  Google Scholar 

  20. Manil L, Perdereau B, Barbaroux C, Brixy F (1994) Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma. Int J Cancer 57:245–246

    PubMed  CAS  Google Scholar 

  21. Sautter-Bihl ML, Dorr U, Schilling F, Treuner J, Bihl H (1994) Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma. Semin Oncol 21(5 Suppl 13):38–41

    PubMed  CAS  Google Scholar 

  22. Pashankar FD, O’Dorisio MS, Menda Y (2005) MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use. J Nucl Med 46 Suppl 1:55S–61S.

    PubMed  CAS  Google Scholar 

  23. Manil L, Edeline V, Lumbroso J, Lequen H, Zucker JM (1996) Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 37:893–896

    PubMed  CAS  Google Scholar 

  24. Krausz Y, Keidar Z, Kogan I, Even-Sapir E, Bar-Shalom R, Engel A, Rubinstein R, et al (2003) SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 59:565–573

    Article  Google Scholar 

  25. Andersson P, Forssel-Aronsson E, Johanson V, Wangberg B, Nilsson O, Fjalling M, Ahlman H (1996) Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe 1-octreotide. J Nucl Med 37:2002–2006

    PubMed  CAS  Google Scholar 

  26. Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B (2004) Pheochromocytomas: detection with C-11 hydroxyephedrine PET. Radiology 230:423–428

    PubMed  Google Scholar 

  27. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS (2001) 6-[18F]Fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 7:6–8

    Google Scholar 

  28. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, et al (2003) Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083–4087

    Article  PubMed  CAS  Google Scholar 

  29. Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25:905–913

    Article  PubMed  CAS  Google Scholar 

  30. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G (1997) Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 47:284–289

    Article  PubMed  CAS  Google Scholar 

  31. Bertherat J, Mosnier-Pudar H, Bertagna X (2002) Adrenal incidentalomas. Curr Opin Oncol 14:58–63

    Article  PubMed  Google Scholar 

  32. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Langsjo J, Salmi J, et al. (2004) Imaging of adrenal incidentalomas with PET using C-11 metomidate and 18F-FDG. J Nucl Med 45:972–979

    PubMed  CAS  Google Scholar 

  33. Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H, Niederle B, et al (2004) Positron emission tomography imaging of adrenal masses: (18)F-fluorode-oxyglucose and the 11 β-hydroxylase tracer C-11 metomidate. Eur J Nucl Med Mol Imaging 31:1224–1230

    Article  PubMed  Google Scholar 

  34. Khan TS, Sundin A, Juhlin C, Langstrom B, Bergström M, Eriksson B (2003) 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30:403–410

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Sleiman Naddaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdelhamid H. Elgazzar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Faculty of Medicine Kuwait University Health Sciences Center, PO Box 24923, 13110, Safat, Kuwait

    Abdelhamid H. Elgazzar MD, FCAP (Diplomate, American Board of Pathology Diplomate, American Board of Nuclear Medicine Professor and Chairman) (Diplomate, American Board of Pathology Diplomate, American Board of Nuclear Medicine Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Naddaf, S., Elgazzar, A.H. (2006). Adrenal Gland. In: Elgazzar, A.H. (eds) The Pathophysiologic Basis of Nuclear Medicine. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-47953-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-47953-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23992-5

  • Online ISBN: 978-3-540-47953-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation